BEVITAL AS

Nutrition & Lifestyle

41 biomarkers of 5 different classes from 300μl sample volume on GC- and LC-MS/MS platforms. Contact our experts for any questions or inquiries.

Why did we design this panel?

We developed this targeted metabolomics panel for investigating nutritional status and lifestyle to accurately measure specific nutrients and metabolites, assess status and dietary intake, and understand metabolic responses to intervention. This supports nutrition focused research, and can be used for developing personalized dietary recommendations and lifestyle interventions, improving individual health outcomes and informing public health strategies. The panel supports:

Assessment of Nutritional Status: The panel measures specific vitamins and other nutrients, giving a picture of a person’s current nutritional state. This helps identify deficiencies or excesses that may not be apparent through diet assessment alone.
Personalized Dietary Recommendations: Based on the results, dietary and supplementation recommendations can be tailored to meet the individual’s unique needs, improving overall health and wellbeing.
Early Detection of Deficiencies: The panel can detect deficiencies before symptoms arise, allowing for timely interventions to prevent related health issues.
Monitoring and Managing Chronic Conditions: Many chronic diseases, such as diabetes, cardiovascular disease, and gastrointestinal disorders, are affected by nutrition. Longitudinal monitoring can guide dietary adjustments to better manage these conditions.
Supporting Immune Function: Nutrients like vitamins A, D, and E play a crucial role in immune health. The panel can identify imbalances that may impact immunity, helping prevent infections and improve resilience.

Applications: Aging and frailty, autoimmune diseases, bone health and osteoporosis, cancer prevention, cardiovascular diseases, digestive disorders, exercise and athletic performance, kidney disease, liver disease, mental health, nutrient deficiencies, obesity, pregnancy and prenatal health, type 2 diabetes and metabolic syndrome.

B-vitamins, functional markers, and methyl donors

17 markers by GC- and LC-MS/MS

Measuring B-vitamins, functional markers, and methyl donors is vital for assessing nutritional status and understanding their impact on health and disease. B-vitamins are essential for various metabolic functions, and their levels indicate potential deficiencies or excesses that can lead to adverse health outcomes. Functional markers like homocysteine reflect methylation status, crucial for regulating gene expression and metabolic processes. Dysregulation of methylation is linked to diseases such as cardiovascular conditions and neurological disorders. Methyl donors, including folate and choline, influence epigenetic regulation, affecting gene expression without altering DNA sequences. Imbalances in methyl donor levels can disrupt epigenetic signaling, contributing to disease development. Suboptimal levels of these biomarkers are associated with increased disease risk, making their measurement important for assessing overall health. Additionally, monitoring these biomarkers helps evaluate the effectiveness of treatments and nutritional interventions aimed at improving health outcomes. In short, measuring these biomarkers provides valuable insights into nutritional status, methylation processes, disease risk, and treatment effectiveness, facilitating proactive management of patient health.

Betaine, Choline, Cobalamin, Flavin mononucleotide, Folate, Methylmalonic acid, N1-methylnicotinamide, Nicotinamide, Nicotinic acid, Pyridoxal, 4-Pyridoxic acid, Pyridoxal 5-phosphate, Pyridoxine, Riboflavin, Thiamine, Thiamine monophosphate, Total homocysteine

Fat-soluble vitamins

4 markers by LC-MS/MS

Measuring fat-soluble vitamins (A, D, E, and K) is essential for assessing nutritional status, preventing diseases, and supporting immune function. These vitamins play crucial roles in various physiological functions, including vision, bone health, antioxidant defense, and blood clotting. Deficiencies in fat-soluble vitamins are linked to increased risks of conditions like vision impairment, osteoporosis, oxidative stress-related diseases, and bleeding disorders. Monitoring vitamin levels aids in disease prevention and management and informs therapeutic development. Additionally, fat-soluble vitamins modulate immune function and inflammation, with vitamin D and A being particularly important in immune regulation. Research on fat-soluble vitamins guides interventions to improve health outcomes and informs public health strategies such as food fortification programs. Overall, measuring fat-soluble vitamins is crucial for promoting optimal health and well-being and reducing the burden of deficiency-related diseases.

25-Hydroxy vitamin D2, 25-Hydroxy vitamin D3, α-Tocopherol (Vit. E), All-trans retinol (Vit. A), Phylloquinone (Vit. K1), y-Tocopherol (Vit. E)

Essential amino acids metabolites

9 markers by GC-MS/MS

Measuring essential amino acids (EAAs) is crucial for understanding protein synthesis, assessing nutritional status, and evaluating metabolic functions crucial for overall health. EAAs serve as building blocks for protein synthesis, impacting muscle health and tissue repair. Imbalances in EAAs can disrupt metabolic pathways, contributing to disease development, and monitoring the metabolites can help in assessment of disease risk and progression, and can guide dietary interventions to promote health. Additionally, EAAs play a role in sports nutrition, influencing muscle recovery and performance. Research on EAAs informs therapeutic development for conditions related to amino acid metabolism. In summary, measuring EAAs provides insights into nutritional adequacy, metabolic function, disease risk, and sports performance, aiding in proactive health management and intervention strategies.

Histidine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Threonine, Tryptophan, Valine

Meat & fish intake

4 markers by GC- and LC-MS/MS

3-Methylhistidine (3-MH) is formed by methylation of histidine as a posttranslational modification of actin and myosin. 3-MH is liberated during degradation of myofibrillar proteins, is not metabolized or used in proteosynthesis, but is excreted unchanged into the urine. 3-MH in plasma or urine may serve as a marker of muscle degradation, but also reflects dietary meat intake. Endogenous versus dietary 3-MH can be distinguished by simultaneous measurement of 1-Methylhistidine (1-MH), which is not formed in humans but occurs in skeletal muscle of several other species.
Choline, phosphatidylcholine and L-carnitine are cleaved by the gut microbiota to trimethylamine (TMA), which is oxidized to trimethylamine-N-oxide (TMAO) in the liver. TMAO seems to be proatherogenic in animal models and plasma levels are associated with risk of cardiovascular and other diseases in humans. Circulating TMAO increases during renal failure, and has been regarded as an uremic toxin. Many species of fish and seafood naturally contain high levels of TMAO, which serves as an osmolyte to protect against pressure and cold in aquatic environments. Consuming fish or seafood can lead to a significant but transient increase in circulating TMAO levels in humans.
β-Alanine is a naturally occurring beta-amino acid that is formed during degradation of carnosine and anserine, but also serves as a precursor for the synthesis of these histidine-containing dipeptides. This explains why beta-alanine may reflect the amount of carnosine/anserine in the body, and serves as a biomarker for the consumption of meat, especially red meat. β-Alanine is used as a supplement. High levels, as encountered in some inborn errors of metabolism causing hyper-beta-alaninemia, may act as a neurotoxin and as a mitochondrial toxin. Circulating levels is inversely associated with dementia.

Methylhistidine, 3-Methylhistidine, β-Alanine, Creatine, Creatinine, TMAO

Tobacco use & coffee intake

3 markers by LC-MS/MS

Cotinine is a stable metabolite of nicotine, and is the most widely used biomarker to measure tobacco use and exposure, i.e. both active and passive smoking. Serum cotinine has a half-life of 15 to 40 h and reflects tobacco exposure during the prior 3 to 5 days. The half-life of cotinine is longer than that of nicotine. Thus, the cotinine concentration is therefore rather stable throughout the day.
Trans-3′-hydroxycotinine (OHCot) is the main metabolite of cotinine with a half-life of 6.6 h. The metabolism of cotinine to OHCot is mediated by the enzyme cytochrome p450 2A6 (CYP2A6), encoded by the highly polymorphic CYP2A6 gene, with genotypes strongly associated with nicotine clearance and the nicotine metabolite ratio (NMR), defined as OHCot:cotinine. Other factors, including ethnicity, sex, hormones, smoking intensity, mentholated cigarettes, alcohol use, BMI, are weak predictors of NMR, and account for less than 8 % of NMR variation. Thus, NMR, OHCot/cotinine ratio, is a marker of CYP2A6 activity, and individuals can be categorized into “slow” versus “normal/fast metabolizers” based on their NMR value. The status of “slow metabolizer” has been associated with less nicotine dependence, lower smoking intensity, higher rates of smoking cessation and lower risk of lung cancer.
Trigonelline is a phytohormone particularly abundant in coffee beans, and is a marker of coffee consumption. Roasting of coffee beans partially converts trigonelline to nicotinic acid.

Cotinine, Trans-3-hydroxycotinine, Trigonelline

Scroll to Top

Get Bevital Publications Matching Your Research

Per Christian Eriksen

Øivind

Per Magne Ueland has been Professor at the University of Bergen 1987-2018. He is one of the founders of Bevital AS and the scientific advisor in Bevital since 2023. His interests includes biomarkers related to nutrition, inflammation, ageing and life-style related chronic diseases. Per is committed to the development of precise, high-throughput mass spectrometry methods, tailored for metabolic profiling of biobank specimens from large cohorts.

Ove completed his education in Biomedical Science at the Western Norway University of Applied Sciences, supplemented by specialized training in Electrical Engineering and Electronics at the Royal Norwegian Naval Training Establishment and the National Institute of Technology. With many years of experience as a biomedical scientist in hospital laboratories—specializing primarily in microbiology—he brings a unique blend of clinical and technical expertise to his work. Ove focuses on the design and prototyping of electronics, as well as the service and maintenance of laboratory instrumentation, ensuring that technical equipment and workflows remain precise and reliable for research-focused activities.

Lena holds a master’s degree in biology from the University of Bergen, where her thesis focused on identifying whale skeletons using zooarchaeology by mass spectrometry (ZooMS). At Bevital, she works with LC‑MS/MS analyses and method development, focusing on accurate and reliable testing of biological samples. She is dedicated to ensuring precise and high‑quality results that contribute to reliable scientific outcomes and support ongoing research efforts.

Marit holds a degree in chemical engineering from Bergen Ingeniørhøyskole, which is now part of the Western Norway University of Applied Sciences. She works with quantitative analysis and method development on LC-MS/MS at the laboratory of Bevital AS.

Randi holds a Master of Science in Chemical Process Engineering from the Norwegian University of Science and Technology (NTNU). She has been part of Bevital since its very beginning, contributing her expertise primarily to the LC-MS/MS platforms, but also to the microbiological assays. In 2021, she stepped into the role of Manager/CEO, where she is dedicated to strengthening Bevital’s innovative profile and ensuring the company’s continued growth and success. She is especially motivated by advancing research that improves health insights and by fostering collaboration that drives scientific and technological progress.

Ove completed a bachelor’s degree in Biomedical Laboratory Sciences at the Western Norway University of Applied Sciences in Bergen. With extensive experience in method development and expertise in GC-MS/MS, he specializes in optimizing analytical techniques for research-focused studies. At Bevital, Ove is dedicated to advancing laboratory methods and workflows, contributing to innovative research through precise and reliable analytical solutions.

Lene holds a bachelor’s degree in Biomedical Laboratory Science from the Western Norway University of Applied Sciences, where she is also completing her master’s degree in Medical Laboratory Technology, expected to graduate in 2026. Her master’s thesis focuses on method validation in fatty acid analysis. At Bevital, she works with GC-MS/MS analyses, routinely performing SCFA measurements and emphasizing accurate and reliable testing of biological samples. With her strong laboratory background, Lene is committed to delivering high-quality results that support medical research.

Klaus earned his PhD in physics from the University of Münster in Germany. For more than thirty years he has specialized in Time‑of‑Flight mass spectrometry, contributing innovative approaches to SNP genotyping and protein quantification. Together with his colleague Lene Njåstad, he oversees Bevital’s Olink Proteomics service. He also leads Bevital’s website and media design efforts, ensuring a clear and informative public presence.

Adrian holds a PhD in diabetes research, along with bachelor’s and master’s degrees in biomedical science and public health, respectively. With over 20 years of experience in laboratory science, he leads high-precision metabolite analyses and method development at Bevital. His expertise centers on quantifying biomarkers, metabolite classes, and metabolic pathways related to nutrition, cardiovascular and neurodegenerative diseases, and cancer. Adrian is committed to advancing research quality and actively collaborates nationally and internationally, leveraging targeted metabolomics to support innovative, multidisciplinary research.

Statistical power is the probability that a statistical test will correctly reject a false null hypothesis (H0​) when a specific alternative hypothesis (H1​) is true. H0​ is the null hypothesis, which states there is no effect or no difference. H1​ is the alternative hypothesis, which states there is a real effect or difference. Alpha (α) is the probability of a Type I error (a false positive), which is the risk of incorrectly rejecting the H0​ when it is actually true. You set this value before the experiment, commonly at 0.05. Beta (β) is the probability of a Type II error (a false negative), which is the risk of failing to reject the H0​ when it is actually false.

Power is calculated as 1−β. Increasing power means you are decreasing the probability of making a Type II error.

Several factors can be adjusted to increase the power of a statistical test:

  • Effect Size: This is the magnitude of the difference you are trying to detect. A larger effect size is easier to detect, thus increasing power. 

  • Sample Size: The number of observations in a study. A larger sample size provides more information about the population, reducing the margin of error and increasing the power to detect a true effect.

  • Variation: Refers to the spread or standard deviation of the data within the population. Less variation makes it easier to distinguish a real effect from random noise, thereby increasing power.

  • Alpha (): Increasing the alpha level (e.g., from 0.05 to 0.10) also increases power, but at the cost of a higher risk of a Type I error. This trade-off is often undesirable.

579 entries « 1 of 29 »
1.

Walzik, David; Wenzel, Charlotte; Strotkötter, Jule Elisabeth; Hoenen, Leon; Chirino, Tiffany Y Wences; Trebing, Sina; McCann, Adrian; Ueland, Per Magne; Zimmer, Philipp; Joisten, Niklas

Systemic metabolite kinetics mirror skeletal muscle energy metabolism during acute aerobic exercise Journal Article

In: Am J Physiol Cell Physiol, vol. 330, no. 1, pp. C111–C118, 2026, ISSN: 1522-1563.

Abstract | Links | BibTeX

2.

Klaassen-Dekker, Niels; Zoetendal, Erwin G; Capuano, Edoardo; Winkels, Renate M; van Duijnhoven, Fränzel Jb; van Heek, N Tjarda; Kruyt, Flip M; Ulvik, Arve; McCann, Adrian; Ueland, Per Magne; de Wilt, Johannes Hw; Kampman, Ellen; Kok, Dieuwertje E

Preoperative plasma short- and branched-chain fatty acids in relation to risk of complications after colorectal cancer surgery: a prospective cohort study Journal Article

In: Am J Clin Nutr, vol. 122, no. 6, pp. 1579–1590, 2025, ISSN: 1938-3207.

Abstract | Links | BibTeX

3.

Linde, Anja; Gerdts, Eva; Fevang, Bjørg T; Ulvik, Arve; Ueland, Per M; Meyer, Klaus; Kringeland, Ester; Midtbø, Helga

Factors associated with left ventricular mass during disease modifying antirheumatic drug therapy in patients with rheumatoid arthritis: the Joint Heart study Journal Article

In: Int J Cardiol Cardiovasc Risk Prev, vol. 27, pp. 200521, 2025, ISSN: 2772-4875.

Abstract | Links | BibTeX

4.

Wenzel, Charlotte; Walzik, David; Wences, Tiffany; Trebing, Sina; Meyer, Klaus; Groll, Andreas; Zimmer, Philipp; Joisten, Niklas

Immunological Protein Signature During Acute Exercise Journal Article

In: Acta Physiol (Oxf), vol. 241, no. 12, pp. e70125, 2025, ISSN: 1748-1716.

Links | BibTeX

5.

Kvestad, Ingrid; Ulak, Manjeswori; McCann, Adrian; Chandyo, Ram K; Hysing, Mari; Schwinger, Catherine; Ranjitkar, Suman; Ueland, Per Magne; Basnet, Sudha; Strand, Tor A

The effect of vitamin B12 supplementation during pregnancy on early motor performance. Secondary analyses from a double-blinded randomized controlled trial Journal Article

In: J Nutr, pp. 101305, 2025, ISSN: 1541-6100.

Abstract | Links | BibTeX

6.

Kupjetz, Marie; Langeskov-Christensen, Martin; Riemenschneider, Morten; Inerle, Stefan; Ligges, Uwe; Gaemelke, Tobias; Patt, Nadine; Bansi, Jens; Gonzenbach, Roman Rudolf; Reuter, Marcel; Rosenberger, Friederike; Meyer, Tim; McCann, Adrian; Ueland, Per Magne; Eskildsen, Simon Fristed; Nygaard, Mikkel Karl Emil; Joisten, Niklas; Hvid, Lars; Dalgas, Ulrik; Zimmer, Philipp

Persons With Multiple Sclerosis Reveal Distinct Kynurenine Pathway Metabolite Patterns: A Multinational Cross-Sectional Study Journal Article

In: Neurol Neuroimmunol Neuroinflamm, vol. 12, no. 6, pp. e200461, 2025, ISSN: 2332-7812.

Abstract | Links | BibTeX

7.

Sandvig, Heidi Vihovde; Saltvedt, Ingvild; Edwin, Trine Holt; Aam, Stina; Alme, Katinka Nordheim; Eldholm, Rannveig Sakshaug; Lydersen, Stian; Mollnes, Tom Eirik; Munthe-Kaas, Ragnhild; Ueland, Per Magne; Ulvik, Arve; Wethal, Torgeir; Knapskog, Anne-Brita

Associations between systemic inflammation and cognitive trajectories post-stroke Journal Article

In: Sci Rep, vol. 15, no. 1, pp. 42791, 2025, ISSN: 2045-2322.

Abstract | Links | BibTeX

8.

Knudsen, Andreas Dehlbæk; Gelpi, Marco; Suarez-Zdunek, Moises A; Loft, Josefine A; Ueland, Per Magne; Ostrowski, Sisse Rye; Midttun, Øivind; Martinez, Esteban; Nielsen, Susanne D

Inhibition of Th1-type immune responses in persons with HIV with current statin exposure Journal Article

In: AIDS, 2025, ISSN: 1473-5571.

Abstract | Links | BibTeX

9.

Bråtveit, Marianne; Strømland, Pouda P; Laupsa-Borge, Johnny; Skumsnes, Lillian; Dagsland, Vigdis H; Kvistad, Silje; Vogt, Elinor C; McCann, Adrian; Thorsen, Håvard L; Diamantopoulos, Andreas P; Nedrebø, Bjørn Gunnar; Mellgren, Gunnar; Dankel, Simon N

A Very-Low Energy Fast Involves Increased Adipose Inflammatory Gene Expression: A 6-Day Feeding Trial (FASTOMICS-6) Journal Article

In: J Clin Endocrinol Metab, 2025, ISSN: 1945-7197.

Abstract | Links | BibTeX

10.

Dhar, Indu; Svingen, Gard Ft; Ulvik, Arve; Bjørnestad, Espen Ø; Sagen, Jørn V; Nygård, Ottar K

Serum Vitamin A Is Associated with Variations in the Relationship between Plasma B6 Vitamers and Cardiovascular Disease Risk Journal Article

In: J Nutr, 2025, ISSN: 1541-6100.

Abstract | Links | BibTeX

11.

Jørgensen, Silje F; Braadland, Peder R; Ueland, Thor; Fraz, Mai S A; Michelsen, Annika E; Holm, Kristian; Osnes, Liv T; Trøseid, Marius; Ueland, Per Magne; Fevang, Børre; Aukrust, Pål; Hov, Johannes R

Tryptophan-kynurenine metabolites associate with inflammation and immunologic phenotypes in common variable immunodeficiency Journal Article

In: J Allergy Clin Immunol, vol. 156, no. 3, pp. 814–824.e11, 2025, ISSN: 1097-6825.

Abstract | Links | BibTeX

12.

Vilar, Ana; Bayes-Marin, Ivet; Álvarez-Salazar, Samantha; Piqueras-Marques, Jorge; Vila, Santiago Batlle; Forero, Carlos G

Prevalence of depressive symptoms in the general population with a fully structured interview with skips vs. unconditional sequential assessment: implications for clinical and psychiatric epidemiology studies Journal Article

In: J Psychiatr Res, vol. 189, pp. 424–434, 2025, ISSN: 1879-1379.

Abstract | Links | BibTeX

13.

Bjørkevoll, Sol Maja G; O'Keeffe, Maria; Konijnenberg, Carolien; Solvik, Beate S; Sødal, Alida F; Kaldenbach, Siri; McCann, Adrian; Ueland, Per M; Kvestad, Ingrid; Ersvær, Elisabeth; Holten-Andersen, Mads N; Bakken, Kjersti S; Strand, Tor A

Infant vitamin B12 status and its predictors - cross-sectional baseline results from an ongoing randomized controlled trial Journal Article

In: Am J Clin Nutr, vol. 122, no. 3, pp. 803–810, 2025, ISSN: 1938-3207.

Abstract | Links | BibTeX

14.

Holthuijsen, Daniëlle D B; van Roekel, Eline H; Bours, Martijn J L; Ueland, Per M; Breukink, Stéphanie O; Janssen-Heijnen, Maryska L G; Konsten, Joop L; Keulen, Eric T P; McCann, Adrian; Brezina, Stefanie; Gigic, Biljana; Kok, Dieuwertje E; Ulrich, Cornelia M; Weijenberg, Matty P; Eussen, Simone J P M

Modeling how iso-caloric macronutrient substitutions are longitudinally associated with plasma kynurenines in colorectal cancer survivors up to 12 months post-treatment Journal Article

In: J Nutr Biochem, vol. 141, pp. 109910, 2025, ISSN: 1873-4847.

Abstract | Links | BibTeX

15.

Valim, Valéria; Oliveira, Fabíola R; Miyamoto, Samira T; Serrano, Érica V; Balarini, Gabriela M; Tanure, Leandro A; Ferreira, Gilda A; Zandonade, Eliana; Brun, Johan G; Jonsson, Malin; Maeland, Elisabeth; Ulvik, Arve; Ueland, Per Magne; Jonsson, Roland; Mydel, Piotr M

Kynurenines and neopterin are interferon-gamma-inducible biomarkers for Sjögren's disease Journal Article

In: Rheumatology (Oxford), vol. 64, no. 7, pp. 4404–4413, 2025, ISSN: 1462-0332.

Abstract | Links | BibTeX

16.

Bakker, Lieke; Ramakers, Inez H G B; van Greevenbroek, Marleen M J; Backes, Walter H; Jansen, Jacobus F A; Schram, Miranda T; van der Kallen, Carla J H; Schalkwijk, Casper G; Wesselius, Anke; Ulvik, Arve; Ueland, Per M; Verhey, Frans R J; Eussen, Simone J P M; Köhler, Sebastian

The kynurenine pathway and markers of neurodegeneration and cerebral small vessel disease: The Maastricht Study Journal Article

In: J Neurol Sci, vol. 474, pp. 123522, 2025, ISSN: 1878-5883.

Abstract | Links | BibTeX

17.

Gordon, Shane; Hoey, Leane; McNulty, Helene; Keenan, Jordan; Pangilinan, Faith; Brody, Lawrence C; Ward, Mary; Strain, J J; McAnena, Liadhan; McCann, Adrian; Molloy, Anne M; Cunningham, Conal; McCarroll, Kevin; Hughes, Catherine F

Associations of one-carbon metabolism, related B-vitamins and ApoE genotype with cognitive function in older adults: identification of a novel gene-nutrient interaction Journal Article

In: BMC Med, vol. 23, no. 1, pp. 440, 2025, ISSN: 1741-7015.

Abstract | Links | BibTeX

18.

Belen, Sergen; Patt, Nadine; Kupjetz, Marie; Ueland, Per M; McCann, Adrian; Gonzenbach, Roman; Bansi, Jens; Zimmer, Philipp

Vitamin B status is related to disease severity and modulated by endurance exercise in individuals with multiple sclerosis: a secondary analysis of a randomized controlled trial Journal Article

In: Am J Clin Nutr, vol. 121, no. 6, pp. 1403–1414, 2025, ISSN: 1938-3207.

Abstract | Links | BibTeX

19.

Dahl, Tuva B; Aftab, Friha; Prebensen, Christian; Berdal, Jan-Erik; Ueland, Thor; Barratt-Due, Andreas; Riise, Anne Ma Dyrhol; Ueland, Per Magne; Hov, Johannes R; Trøseid, Marius; Aukrust, Pål; Gregersen, Ida; Myhre, Peder L; Omland, Torbjørn; Halvorsen, Bente

Imidazole propionate is increased in severe COVID-19 and correlates with cardiac involvement Miscellaneous

2025, ISSN: 1532-2742.

Links | BibTeX

20.

Park, Jin Young; Puyvelde, Heleen Van; Regazzetti, Lea; Clasen, Joanna L; Heath, Alicia K; Eussen, Simone; Ueland, Per Magne; Johansson, Mattias; Biessy, Carine; Zamora-Ros, Raul; Huerta, José María; Sánchez, Maria-Jose; Ocke, Marga; Schulze, Matthias B; Schiborn, Catarina; Braaten, Tonje Bjørndal; Skeie, Guri; Sacerdote, Carlotta; Castilla, Jesús; Karlsson, Therese; Johansson, Ingegerd; Kyrø, Cecilie; Tjønneland, Anne; Tong, Tammy Y N; Katzke, Verena; Bajracharya, Rashmita; Lasheras, Cristina; Midttun, Øivind; Vollset, Stein Emil; Vineis, Paolo; Masala, Giovanna; Amiano, Pilar; Tumino, Rosario; Baldassari, Ivan; Weiderpass, Elisabete; Riboli, Elio; Gunter, Marc J; Freisling, Heinz; Rinaldi, Sabina; Muller, David C; Huybrechts, Inge; Ferrari, Pietro

Association Between Dietary Intake and Blood Concentrations of One-Carbon-Metabolism-Related Nutrients in European Prospective Investigation into Cancer and Nutrition Journal Article

In: Nutrients, vol. 17, no. 12, 2025, ISSN: 2072-6643.

Abstract | Links | BibTeX

579 entries « 1 of 29 »

Olink Proteomics

Please fill out the fields below (*required).
We will respond to you ASAP.
Thank you!

Customized analyses

Please fill out the fields below (*required).
We will reply to you soon for a detailed project discussion.
Thank you for reaching out to Bevital!

Mix-and-Match

Please fill out the fields below (*required).
We will respond to you as soon as possible.

Ready-to-Run

Please fill out the fields below (*required).
We will respond ASAP.
Thank you!

Thanks for joining!

Get updates about new method developments, publications and comming events.